The chemical class designated as SH3 and PX domains 2A Activators pertains to compounds that specifically interact with and modulate the activity of proteins possessing the SH3 (Src Homology 3) and PX (Phox Homology) domains. The SH3 domain is a small protein domain of approximately 50 amino acids that is known for its role in mediating protein-protein interactions through recognizing and binding to proline-rich motifs within a wide variety of intracellular signaling proteins. This domain is a critical component in a multitude of cellular processes, particularly those involving the assembly of protein complexes that are essential for the regulation of cellular morphology and motility. The PX domain, on the other hand, typically binds phosphoinositides and is integral in targeting proteins to different membranes, thereby influencing membrane trafficking and the modulation of signaling pathways associated with membrane dynamics.
Activators targeting these domains can influence a broad spectrum of intracellular signaling cascades by altering the conformational states of the SH3 and PX domains, thereby affecting their interaction affinity with natural binding partners. Such modulation can result in the amplification or attenuation of downstream signaling processes, as these domains are pivotal in the orchestration of complex cellular events, including cytoskeletal rearrangement, vesicular trafficking, and cellular proliferation. The SH3 domain, with its role in assembling complexes through recognizing polyproline motifs, can be influenced by activators to either enhance or diminish these protein-protein interactions. Similarly, activators that interact with the PX domain may affect the domain's lipid-binding properties, which can have profound effects on the localization and function of PX domain-containing proteins. Understanding and manipulating the activity of these domains through specific activators offers a powerful tool for dissecting the intricate web of cellular signaling networks.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor that can lead to gene demethylation and could upregulate SH3PXD2A expression by altering epigenetic marks. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, Trichostatin A may increase transcription of various genes, including possibly SH3PXD2A, by affecting chromatin structure. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
This PPARγ agonist is known to influence gene expression profiles in cells and could potentially impact SH3PXD2A expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor like LY294002 can alter cell survival and growth pathways, potentially affecting SH3PXD2A expression. | ||||||